BELLE Capital - Crunchbase Company Profile & Funding

Overview

BELLE Capital

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About BELLE Capital

CB Rank

369412

BELLE Capital is an early stage angel fund for building companies.

Founded

obfuscation

Private

Douglas, Michigan, United States

101-250

www.bellevc.com

Venture Capital

Key People

Irene G. Hrusovsky: Managing Director
Past Role: EraGen Biosciences, Co-Founder, President, and CEO
Michelle Hanks: CPA

Details

Legal Name

BELLE Capital USA, LP

Operating Status

Active

Number of Exits

obfuscation

Founders

Lauren Flanagan

Investor Type

obfuscation

Investment Stage

obfuscation

Phone Number

(313)737-1179

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Prediction

See this Growth Prediction

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Investments

Investment Breakdown

Diversity Investments

Number of Investments

Number of Exits

obfuscation

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	TO THE MARKET	—	Series A - TO THE MARKET	obfuscated obfuscation
obfuscated obfuscation	TO THE MARKET	—	Series A - TO THE MARKET	obfuscated obfuscation
obfuscated obfuscation	TO THE MARKET	—	Series A - TO THE MARKET	obfuscated obfuscation
obfuscated obfuscation	TO THE MARKET	—	Series A - TO THE MARKET	obfuscated obfuscation
obfuscated obfuscation	TO THE MARKET	—	Series A - TO THE MARKET	obfuscated obfuscation

Investment Breakdown

Number of Investments

Number of Exits

obfuscation

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	TO THE MARKET	—	Series A - TO THE MARKET	obfuscated obfuscation
obfuscated obfuscation	TO THE MARKET	—	Series A - TO THE MARKET	obfuscated obfuscation
obfuscated obfuscation	TO THE MARKET	—	Series A - TO THE MARKET	obfuscated obfuscation
obfuscated obfuscation	TO THE MARKET	—	Series A - TO THE MARKET	obfuscated obfuscation
obfuscated obfuscation	TO THE MARKET	—	Series A - TO THE MARKET	obfuscated obfuscation

Diversity Investments

Number of Diversity Investments

Announced Date	Organization Name	Diversity Spotlight	Funding Round	Money Raised
obfuscated obfuscation	TO THE MARKET	Women Founded, Women Led	Series A - TO THE MARKET	obfuscated obfuscation
obfuscated obfuscation	TO THE MARKET	Women Founded, Women Led	Seed Round - TO THE MARKET	obfuscated obfuscation
obfuscated obfuscation	Opus Genetics(formerly Ocuphire Pharma)	Women Founded, Women Led	Seed Round - Opus Genetics(formerly Ocuphire Pharma)	obfuscated obfuscation
obfuscated obfuscation	Vyv	Women Founded, Women Led	Seed Round - Vyv	obfuscated obfuscation
obfuscated obfuscation	Joylux	Women Founded, Women Led	Series A - Joylux	obfuscated obfuscation
obfuscated obfuscation	Digsite	Women Founded, Women Led	Seed Round - Digsite	obfuscated obfuscation